Campbell Robert E

Avg. Two Year Performance

(59%) Avg. Purchase Return
(26%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(10%)(1%)(32%)(59%)
Purchase Success Rate1 of 30 of 31 of 31 of 30 of 3
Average Sale Return----------
Sale Success Rate----------

Barrier Therapeutics Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--